Ate-Bev Early Response Prediction Model in Advanced HCC
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
- Status
- UNKNOWN
- Phase
- PHASE2
The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE2
FMT in IT-refractory HCC - FAB-HCC Pilot Study
- Status
- COMPLETED
- Phase
- PHASE2
HCC Staging Modified by Tumor Micronecrosis
- Status
- COMPLETED
- Phase
- N/A
Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
- Status
- RECRUITING
- Phase
- NA
Diagnostic Accuracy of APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among Cirrhotic Patients
- Status
- UNKNOWN
- Phase
- N/A
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC
- Status
- UNKNOWN
- Phase
- NA
PAtient-PHYsician Relationship Assessment
- Status
- COMPLETED
- Phase
- N/A
Domvanalimab and Zimberelimab in Advanced Liver Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer
- Status
- UNKNOWN
- Phase
- NA
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC
- Status
- TERMINATED
- Phase
- NA
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
- Status
- RECRUITING
- Phase
- NA
Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic Patients
- Status
- UNKNOWN
- Phase
- N/A